Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Allogeneic ex vivo expanded umbilical cord blood cells

EU orphan designation number: EU/3/09/649   
Active ingredient: Allogeneic ex vivo expanded umbilical cord blood cells
Indication: Treatment of Hodgkin lymphoma
Sponsor: Regulatory Resources Group Ltd
Innovation House, Albany Park, Camberley, Surrey GU16 7PL, United Kingdom

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
30/07/2009 Centralised Orphan - Designation EMEA/OD/034/09 (2009)6040 of 24/07/2009
15/09/2011 Other procedure EMEA/OD/034/09
29/07/2013 Centralised Orphan - Transfer of orphan designation EMEA/OD/034/09/T/01 (2013)4956 of 25/07/2013